医学
列线图
接收机工作特性
内科学
比例危险模型
肿瘤科
肝细胞癌
切断
Lasso(编程语言)
单变量
多元分析
生存分析
多元统计
统计
量子力学
计算机科学
物理
万维网
数学
作者
Chenglei Yang,Wanyan Xiang,Zongze Wu,Nannan Li,Guoliang Xie,Juntao Huang,Lixia Zeng,Hongping Yu,Bang‐De Xiang
出处
期刊:BMC Cancer
[BioMed Central]
日期:2025-01-10
卷期号:25 (1)
被引量:1
标识
DOI:10.1186/s12885-024-13399-9
摘要
In clinical practice, CK19 can be an important predictor for the prognosis of HCC. Due to the high incidence and mortality rates of HCC, more effective and practical prognostic prediction models need to be developed urgently. A total of 1,168 HCC patients, who underwent radical surgery at the Guangxi Medical University Cancer Hospital, between January 2014 and July 2019, were recruited, and their clinicopathological data were collected. Among the clinicopathological data, the optimal cutoff value of CK19-positive HCC was determined by calculating the area under the curve (AUC) using survival analysis and time-dependent receiver operating characteristic (timeROC) curve analysis. The predictors were screened using univariate and multivariate COX regression and least absolute shrinkage and selection operator (LASSO) regression to construct nomogram prediction models, and their predictive potentials were assessed using calibration curves and AUC values. The 0% positive rate of CK19 was considered the optimal cutoff value to predict the poor prognosis of CK19-positive HCC. The survival analysis of 335 CK19-positive HCC showed no significant statistical differences in the overall survival (OS) and disease-free survival (DFS) of CK19-positive HCC patients. A five-factor risk (CK19, CA125, Edmondson, BMI, and tumor number) scoring model and an OS nomograph model were constructed and established, and the OS nomograph model showed a good predictive performance and was subsequently verified. A 0% expression level of CK19 protein may be an optimal threshold for predicting the prognosis of CK19-positive HCC. Based on this, CK19 marker a good nomogram model was constructed to predict HCC prognosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI